Allium hookeri extract
Dietary Supplementtake two capsules per day (486 mg/day) for 8 weeks
Other names: AH
NCT Number: NCT03330366
The researchers investigated the anti-diabetic effects of Allium hookeri root extract for Korean prediabetic participants.
Looking for future studies?
Notify Me20 year–70 year
All sexes
Interventional
Not applicable
Allium hookeri root is widely consumed as a vegetable and herbal medicine in Asia. Although the antidiabetic activities of Allium hookeri have been documented in animal studies, the improved effects of Allium hookeri on human are not clear. Therefore, in this study, the researchers investigated whether Allium hookeri root extract could be effective in reducing the risk of type 2 diabetes in individuals with prediabetes.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
take two capsules per day (486 mg/day) for 8 weeks
Other names: AH
take two capsules per day
Time frame: 8 weeks
Changes of fasting and postprandial glucose during OGTT were assessed before and after the intervention
Time frame: 8 week
Changes of blood insulin were assessed before and after the intervention
Time frame: 8 week
Changes of C-peptide were assessed before and after the intervention
Time frame: 8 week
Changes of HbA1c were assessed before and after the intervention
Chonbuk National University Hospital
Other
An 8 Week, Randomized, Double-blind, Placebo-controlled Crossover Clinical Trial of Allium Hookeri Root Extract on Anti-diabetic Effects
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07618663
Diabetes Mellitus, Endocrine System Diseases
Lahore, Shaikhupura, Pakistan
View Trial DetailsNCT05351359
Diabetes Mellitus, Diabetes Mellitus, Type 2
Prague, Czechia
View Trial DetailsNCT07713394
Behavior, Body Weight
Erzurum, Turkey, Turkey (Türkiye)
View Trial DetailsNCT07710898
Diabete Mellitus, Diabetes Mellitus
Lahore, Pakistan
View Trial Details